MENU
Advertisement
Table of Contents
Supplement
September/October 2012 Supplement
Interventional Treatment of Venous Disease
Understanding and addressing this unmet need.
Sponsored by Covidien
Issue
Access and Closure
Techniques and Strategies for Getting In and Getting Out
View Issue
Introduction
Why Treat Superficial Venous Disease?
Focusing only on the heart and arteries isn't enough.
By James D. Joye, DO, FACC
Looking Beyond Arteries
Integrating venous disease management into an existing cardiology practice.
By Paul Kramer, MD, FACC, FSCAI
The Case for Treating Venous Disease
Balancing the “red” and “blue” in practice.
By Ernesto Rivera, MD
Rethinking Your Peripheral Practice
Incorporating treatment of venous disease.
By Michelle Sloan, RN, MSN, APN-BC
enVast™: Engineered for Coronary Thrombectomy
By Marco Valgimigli, MD, PhD
AeroShield™ Elite: Passive Protection Without Compromise
By William Gray, MD
Operationalizing Radiation Safety in Cardiovascular Programs
By Denise Busman, MSN, RN, CPHQ, FACC
Modern Valve Intervention Workflows: Maintaining Efficiency Across Applications and Indications
With Mazen Albaghdadi, MD, MSc, and Natalia C. Berry, MD, MBA
Contemporary Strategies in Minimalist TAVR
With Yousif Ahmad, MBBS, PhD, FACC, FSCAI; Tara L. Jones, MD, PharmD; Dhaval S. Kolte, MD, MPH, PhD, FACC, FSCAI; and John T. Saxon, MD
Latest Issues
2026 Digital Exclusive No. 3
September/October 2026
2026 Digital Exclusive No. 2
2026 Digital Exclusive No. 1
View All Issues